132.65
price down icon2.72%   -3.71
after-market アフターアワーズ: 132.90 0.25 +0.19%
loading
前日終値:
$136.36
開ける:
$136.36
24時間の取引高:
1.56M
Relative Volume:
1.10
時価総額:
$19.45B
収益:
$9.61B
当期純損益:
$1.53B
株価収益率:
12.68
EPS:
10.46
ネットキャッシュフロー:
$1.85B
1週間 パフォーマンス:
-4.65%
1か月 パフォーマンス:
+2.61%
6か月 パフォーマンス:
-5.17%
1年 パフォーマンス:
-35.04%
1日の値動き範囲:
Value
$132.04
$136.36
1週間の範囲:
Value
$132.04
$142.32
52週間の値動き範囲:
Value
$110.03
$206.70

Biogen Inc Stock (BIIB) Company Profile

Name
名前
Biogen Inc
Name
セクター
Healthcare (1150)
Name
電話
(781) 464-2000
Name
住所
225 BINNEY STREET, CAMBRIDGE, MA
Name
職員
7,605
Name
Twitter
@biogen
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
BIIB's Discussions on Twitter

BIIB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
BIIB
Biogen Inc
132.65 19.99B 9.61B 1.53B 1.85B 10.46
Drug Manufacturers - General icon
LLY
Lilly Eli Co
731.96 658.15B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
175.45 425.77B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
207.92 367.55B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
126.47 245.64B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
83.21 209.99B 63.43B 16.42B 14.72B 6.49

Biogen Inc Stock (BIIB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-21 再開されました Truist Hold
2025-04-28 ダウングレード HSBC Securities Buy → Hold
2025-04-04 ダウングレード Argus Buy → Hold
2025-02-11 開始されました Bernstein Mkt Perform
2025-01-02 ダウングレード Piper Sandler Overweight → Neutral
2024-12-20 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-12-16 ダウングレード Stifel Buy → Hold
2024-12-10 再開されました BofA Securities Neutral
2024-12-09 ダウングレード Jefferies Buy → Hold
2024-11-18 ダウングレード Needham Buy → Hold
2024-11-15 開始されました Wolfe Research Peer Perform
2024-11-14 開始されました Citigroup Neutral
2024-10-31 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-10-10 再開されました Raymond James Mkt Perform
2024-02-14 繰り返されました Needham Buy
2024-02-14 ダウングレード Wells Fargo Overweight → Equal Weight
2024-01-24 ダウングレード UBS Buy → Neutral
2023-12-20 再開されました Cantor Fitzgerald Overweight
2023-12-07 アップグレード Raymond James Mkt Perform → Outperform
2023-09-06 開始されました HSBC Securities Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-24 繰り返されました UBS Buy
2023-05-01 アップグレード Guggenheim Neutral → Buy
2023-04-17 アップグレード Piper Sandler Neutral → Overweight
2022-10-26 アップグレード Goldman Neutral → Buy
2022-10-13 アップグレード Stifel Hold → Buy
2022-10-07 アップグレード Argus Hold → Buy
2022-09-28 アップグレード BMO Capital Markets Market Perform → Outperform
2022-09-28 アップグレード Mizuho Neutral → Buy
2022-09-28 アップグレード Robert W. Baird Neutral → Outperform
2022-04-18 アップグレード Wells Fargo Equal Weight → Overweight
2022-03-08 ダウングレード Stifel Buy → Hold
2022-03-03 アップグレード RBC Capital Mkts Sector Perform → Outperform
2022-02-04 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-02-04 繰り返されました Barclays Equal Weight
2022-02-04 繰り返されました BofA Securities Neutral
2022-02-04 繰り返されました Cowen Outperform
2022-02-04 繰り返されました Morgan Stanley Overweight
2022-02-04 繰り返されました Needham Buy
2022-02-04 繰り返されました Oppenheimer Outperform
2022-02-04 繰り返されました RBC Capital Mkts Sector Perform
2022-02-04 繰り返されました Robert W. Baird Neutral
2022-02-04 繰り返されました Wedbush Neutral
2022-02-04 繰り返されました Wells Fargo Equal Weight
2022-02-04 繰り返されました Wolfe Research Peer Perform
2022-01-13 ダウングレード Guggenheim Buy → Neutral
2022-01-12 ダウングレード Piper Sandler Overweight → Neutral
2021-12-10 再開されました Raymond James Mkt Perform
2021-12-09 再開されました Wells Fargo Equal Weight
2021-12-06 開始されました Goldman Neutral
2021-11-19 開始されました BMO Capital Markets Outperform
2021-09-23 開始されました Needham Buy
2021-06-18 アップグレード Piper Sandler Neutral → Overweight
2021-06-14 繰り返されました Truist Buy
2021-06-11 アップグレード Bernstein Mkt Perform → Outperform
2021-06-10 アップグレード UBS Neutral → Buy
2021-06-08 アップグレード Atlantic Equities Underweight → Neutral
2021-06-08 繰り返されました Barclays Equal Weight
2021-06-08 アップグレード Citigroup Sell → Neutral
2021-06-08 繰り返されました H.C. Wainwright Buy
2021-06-08 繰り返されました Jefferies Buy
2021-06-08 繰り返されました Morgan Stanley Overweight
2021-06-08 繰り返されました RBC Capital Mkts Sector Perform
2021-06-08 アップグレード Robert W. Baird Underperform → Neutral
2021-06-08 繰り返されました Stifel Buy
2021-06-08 アップグレード William Blair Mkt Perform → Outperform
2021-06-07 アップグレード BofA Securities Underperform → Neutral
2021-06-07 アップグレード Cowen Market Perform → Outperform
2021-06-07 アップグレード Raymond James Underperform → Mkt Perform
2021-02-05 ダウングレード DZ Bank Buy → Hold
2021-01-29 アップグレード Stifel Hold → Buy
2020-11-10 アップグレード DZ Bank Hold → Buy
2020-11-09 ダウングレード Atlantic Equities Neutral → Underweight
2020-11-09 ダウングレード BofA Securities Neutral → Underperform
2020-11-09 ダウングレード Cowen Outperform → Market Perform
2020-11-09 繰り返されました H.C. Wainwright Buy
2020-11-04 アップグレード BofA Securities Underperform → Neutral
2020-11-04 アップグレード Jefferies Hold → Buy
2020-11-04 アップグレード Wells Fargo Equal Weight → Overweight
2020-10-28 開始されました UBS Neutral
2020-07-27 アップグレード Morgan Stanley Underweight → Overweight
2020-06-22 ダウングレード Barclays Overweight → Equal Weight
2020-06-22 繰り返されました RBC Capital Mkts Sector Perform
2020-06-09 ダウングレード Bernstein Outperform → Mkt Perform
2020-04-23 ダウングレード Citigroup Neutral → Sell
2020-04-23 ダウングレード Raymond James Mkt Perform → Underperform
2020-03-31 開始されました Wolfe Research Peer Perform
2020-02-27 開始されました Barclays Overweight
2020-01-27 アップグレード Canaccord Genuity Hold → Buy
2019-12-13 アップグレード Credit Suisse Underperform → Neutral
2019-12-02 ダウングレード Robert W. Baird Neutral → Underperform
すべてを表示

Biogen Inc (BIIB) 最新ニュース

pulisher
Aug 28, 2025

What does recent volatility data suggest for Biogen Inc.Options Play & Long-Term Capital Growth Ideas - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Price T Rowe Associates Inc. MD Sells 782,524 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

Visualizing Biogen Inc. stock with heatmapsJuly 2025 Movers & Reliable Volume Spike Alerts - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

HighTower Advisors LLC Has $1.60 Million Stock Position in Biogen Inc. $BIIB - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

Biogen Inc. $BIIB Shares Purchased by Korea Investment CORP - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

US FDA’s ARIA Analysis Adds Earlier Scan To Biogen/Eisai Leqembi Label - insights.citeline.com

Aug 28, 2025
pulisher
Aug 28, 2025

Is Biogen Inc. stock ready for a breakoutRecession Risk & Technical Pattern Recognition Alerts - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Aug 28, 2025
pulisher
Aug 28, 2025

FDA recommends more monitoring of Alzheimer's patients on Eisai-Biogen's drug Leqembi - Reuters

Aug 28, 2025
pulisher
Aug 28, 2025

FDA recommends more monitoring of Alzheimer's patients on Biogen's drug Leqembi - Reuters

Aug 28, 2025
pulisher
Aug 28, 2025

Regulatory Vigilance and the Future of Biogen’s Leqembi: Balancing Innovation with Risk in Alzheimer’s Drug Development - AInvest

Aug 28, 2025
pulisher
Aug 28, 2025

Will a bounce in Biogen Inc. offer an exit2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Evaluating Biogen Inc. with trendline analysisTrade Risk Summary & Expert Curated Trade Setup Alerts - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study - Benzinga

Aug 28, 2025
pulisher
Aug 28, 2025

Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight - GlobeNewswire Inc.

Aug 28, 2025
pulisher
Aug 28, 2025

Stock Analysis | Biogen OutlookNavigating Bearish Signals Amid Mixed Analyst Sentiment - AInvest

Aug 28, 2025
pulisher
Aug 28, 2025

Biogen Inc. stock chart pattern explainedJuly 2025 Recap & Fast Entry Momentum Alerts - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Custom watchlist performance reports with Biogen Inc.Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Biogen Inc. $BIIB Shares Purchased by FORA Capital LLC - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

Altrinsic Global Advisors LLC Reduces Stake in Biogen Inc. $BIIB - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

Causeway Capital Management LLC Raises Stock Position in Biogen Inc. $BIIB - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

Synovus Financial Corp Grows Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

Campbell & CO Investment Adviser LLC Reduces Stock Position in Biogen Inc. $BIIB - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

APG Asset Management N.V. Sells 9,014 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 28, 2025
pulisher
Aug 28, 2025

Will Biogen Inc. stock go up soon2025 Market Overview & Fast Moving Market Watchlists - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Developing predictive dashboards with Biogen Inc. data2025 Top Decliners & Low Risk Growth Stock Ideas - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Can volume confirm reversal in Biogen Inc.July 2025 Earnings & Consistent Growth Equity Picks - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Biogen Inc. stock daily chart insights2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Biogen’s Zurzuvae and the Expanding Postnatal Depression Treatment Market: A Catalyst for Long-Term Growth in Maternal Mental Health - AInvest

Aug 28, 2025
pulisher
Aug 27, 2025

Biogen Inc. $BIIB Shares Sold by Northern Trust Corp - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Level Four Advisory Services LLC Buys 8,685 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Multi factor analysis applied to Biogen Inc.2025 Top Gainers & Verified Entry Point Signals - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Dimensional Fund Advisors LP Reduces Holdings in Biogen Inc. $BIIB - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Quantbot Technologies LP Grows Position in Biogen Inc. $BIIB - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

UK Regulator Approves Biogen’s Drug For Treating Postnatal Depression - MSN

Aug 27, 2025
pulisher
Aug 27, 2025

Biogen Dips 0.26% as $0.19B Volume Ranks 491st in Market Activity Amid Global Smart Shelves Market Surge - AInvest

Aug 27, 2025
pulisher
Aug 27, 2025

Can trapped investors hope for a rebound in Biogen Inc.Earnings Miss & Real-Time Volume Analysis Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Biogen wins approval of postpartum depression drug Zurzuvae in UK - Seeking Alpha

Aug 27, 2025
pulisher
Aug 27, 2025

Analyzing drawdowns of Biogen Inc. with statistical toolsEarnings Overview Summary & Weekly Sector Rotation Insights - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Biogen Partnership and Zorevunersen Data Could Be a Game Changer for Stoke Therapeutics (STOK) - simplywall.st

Aug 27, 2025

Biogen Inc (BIIB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general SNY
$49.94
price down icon 0.34%
$112.56
price down icon 1.19%
drug_manufacturers_general PFE
$24.60
price down icon 1.87%
$285.61
price down icon 0.82%
drug_manufacturers_general NVO
$56.11
price down icon 0.58%
drug_manufacturers_general MRK
$83.21
price down icon 1.02%
大文字化:     |  ボリューム (24 時間):